RecruitingNCT04972136
What is this study about?This study evaluates the effectiveness of transcranial magnetic stimulation for people with depression.
In TorontoDepressionDevice studyAges 16–35
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
RecruitingNCT05295888
In TorontoDepressionDevice studyAges 18–65
- Countries
- Canada
- Sponsor
- Unity Health Toronto
RecruitingNCT07188623
In StanfordDepressionBehavioural studyAges 65+
- Countries
- United States
- Sponsor
- Stanford University
Not Yet RecruitingNCT07566104
This study isn't recruiting yet.
In Los AngelesDepressionMedication studyAges 21–60
- Countries
- United States
- Sponsor
- University of California, Los Angeles
Not Yet RecruitingNCT07596914
This study isn't recruiting yet.
Multiple locations, including San FranciscoDepressionDevice studyAges 18+
- Countries
- United States
- Sponsor
- University of California, San Francisco
Not Yet RecruitingNCT07329153
This study isn't recruiting yet.
Multiple locations, including San DiegoDepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
Not Yet RecruitingNCT07480486
This study isn't recruiting yet.
In RabatDepressionStudy assessmentsAges 18+
- Countries
- Morocco
- Sponsor
- Mohammed V University in Rabat
Not Yet RecruitingNCT07052058
This study isn't recruiting yet.
In Porto AlegreDepressionPlacebo comparisonAges 18–65
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
RecruitingNCT06668571
In RochesterDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Mayo Clinic
RecruitingNCT07673913
In AnkaraDepressionDevice studyAges 18–55
- Countries
- Türkiye
- Sponsor
- Gulhane Training and Research Hospital
Not Yet RecruitingNCT07529574
What is this study about?This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
This study isn't recruiting yet.
In SeoulDepressionMedication studyAges 15+
- Countries
- South Korea
- Sponsor
- Jung-Sun Lee
RecruitingNCT07621237
What is this study about?Researchers are comparing TNX-102 SL and placebo to find out how the approaches affect depression symptoms in people with depression.
Multiple locations, including PhoenixDepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Tonix Pharmaceuticals, Inc.
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.